| PERIOD ENDING | 30-Nov-09 | 30-Aug-09 | 31-May-09 | 1-Mar-09 | | Total Revenue | 136,644 | 131,378 | 132,920 | 146,002 | | Cost of Revenue | 98,281 | 95,760 | 96,370 | 111,081 | | | Gross Profit | 38,363 | 35,618 | 36,550 | 34,921 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,641 | 25,602 | 25,877 | 26,408 | | Non Recurring |
-
|
-
| 470 | (470) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,722 | 10,016 | 10,203 | 8,983 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,732) | 418 | 2,902 |
-
| | Earnings Before Interest And Taxes | 20,298 | 11,126 | 13,105 | 8,983 | | Interest Expense | (692) | 373 | 148 | 171 | | Income Before Tax | 20,990 | 10,753 | 12,957 | 8,812 | | Income Tax Expense | 7,120 | 3,778 | 1,975 | 2,644 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,283 | 5,948 | 9,426 | 3,826 | | | Non-recurring Events | | Discontinued Operations | 817 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,100 | 5,948 | 9,426 | 3,826 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,100 | $5,948 | $9,426 | $3,826 |
|
1.52% Nasdaq 
Income Statement
